Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Venlafaxine in the treatment of borderline personality disorder.

Markovitz PJ, Wagner SC.

Psychopharmacol Bull. 1995;31(4):773-7.

PMID:
8851652
2.

Pharmacotherapy of borderline personality disorder.

Hirschfeld RM.

J Clin Psychiatry. 1997;58 Suppl 14:48-52; discussion 53. Review.

PMID:
9418746
3.

Venlafaxine in social phobia.

Kelsey JE.

Psychopharmacol Bull. 1995;31(4):767-71.

PMID:
8851651
4.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
5.

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.

Thase ME, Entsuah AR, Rudolph RL.

Br J Psychiatry. 2001 Mar;178:234-41.

PMID:
11230034
6.

Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.

Stahl SM, Entsuah R, Rudolph RL.

Biol Psychiatry. 2002 Dec 15;52(12):1166-74.

PMID:
12488062
7.

Fluoxetine trial in borderline personality disorder.

Cornelius JR, Soloff PH, Perel JM, Ulrich RF.

Psychopharmacol Bull. 1990;26(1):151-4.

PMID:
2371370
8.

Benztropine for venlafaxine-induced night sweats.

Pierre JM, Guze BH.

J Clin Psychopharmacol. 2000 Apr;20(2):269. No abstract available.

PMID:
10770471
11.

[Fluoxetine in the treatment of borderline personality disorder].

Silva H, Jerez S, Paredes A, Salvo J, Rentería P, Ramírez A, Montes C.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1997 Nov-Dec;25(6):391-5. Spanish.

PMID:
9477607
12.

Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors.

Sáiz-Ruiz J, Ibáñez A, Díaz-Marsá M, Arias F, Padín J, Martín-Carrasco M, Montes JM, Ferrando L, Carrasco JL, Martín-Ballesteros E, Jordá L, Chamorro L.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct;26(6):1129-34.

PMID:
12452535
13.

A preliminary trial of fluoxetine in refractory borderline patients.

Cornelius JR, Soloff PH, Perel JM, Ulrich RF.

J Clin Psychopharmacol. 1991 Apr;11(2):116-20.

PMID:
2056138
14.

The use of newer antidepressants for panic disorder.

Gorman JM.

J Clin Psychiatry. 1997;58 Suppl 14:54-8; discussion 59. Review.

PMID:
9418747
15.

Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.

Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, Schwartz J, Miyawaki E.

J Clin Psychopharmacol. 1995 Feb;15(1):23-9.

PMID:
7714224
16.

[A place for SSRIs in the treatment of severely depressed children and adolescents].

Roobol TH, Buitelaar JK.

Ned Tijdschr Geneeskd. 2008 Aug 2;152(31):1710-2. Dutch.

PMID:
18727599
17.

A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients.

Diaz-Martinez A, Benassinni O, Ontiveros A, Gonzalez S, Salin R, Basquedano G, Martinez RA.

Clin Ther. 1998 May-Jun;20(3):467-76.

PMID:
9663362
18.

Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.

Shelton C, Entsuah R, Padmanabhan SK, Vinall PE.

Int Clin Psychopharmacol. 2005 Jul;20(4):233-8.

PMID:
15933485
19.

A meta-analysis of the effects of venlafaxine on anxiety associated with depression.

Rudolph RL, Entsuah R, Chitra R.

J Clin Psychopharmacol. 1998 Apr;18(2):136-44.

PMID:
9555599

Supplemental Content

Support Center